CDC73 and malignant tumor of parathyroid gland: A genotype-phenotype correlation has been observed among CDC73-mutation carriers such that those with frameshift, nonsense or deletion mutations are nearly 7-fold more likely to develop parathyroid cancer than patients harboring missense CDC73 mutations (99).